Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Lipopolysaccharide transport protein B2FGC complex is an essential ATP-binding cassette (ABC) transporter located in the inner membrane of Gram-negative bacteria [1, 4]. It consists of two LptB ATPase subunits, the transmembrane proteins LptF and LptG, and the bitopic protein LptC [4, 13]. This complex is responsible for the first step of the lipopolysaccharide (LPS) transport pathway: extracting mature LPS from the outer leaflet of the inner membrane and transferring it to a periplasmic protein bridge for delivery to the outer membrane [4, 12]. Because LPS is vital for the structural integrity and antibiotic resistance of Gram-negative bacteria, the LptB2FGC complex is a high-priority target for novel antimicrobial agents [2, 8]. Drugs like zosurabalpin (RG6006) specifically inhibit this complex, leading to the accumulation of LPS in the inner membrane and subsequent bacterial cell death [2]. This target is particularly relevant for treating multidrug-resistant infections, such as those caused by carbapenem-resistant Acinetobacter baumannii [2]. The complex also exhibits regulatory mechanisms where the LptC transmembrane helix modulates ATPase activity to ensure efficient transport [13, 11].
Inhibition of the LptB2FGC complex, which blocks the transport of lipopolysaccharide from the inner membrane to the outer membrane, leading to bacterial cell death.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide transport protein B2FGC complex (LptB2FGC).